Cambridge, U.K.-based digital health company Congenica’s genomic interpretation software has earned the CE mark.

The software platform, also called Congenica, provides rapid analysis of genomic data to identify patients with rare hereditary genomic disorders.

The software can either be loaded into local computers or used via the cloud and can be integrated with existing medical record and laboratory management systems, the company said.